165 related articles for article (PubMed ID: 32490726)
1. Thromboinflammatory response in SARS-CoV-2 sepsis.
Maiese A; Passaro G; Matteis A; Fazio V; Raffaele R; Paolo MD
Med Leg J; 2020 Jul; 88(2):78-80. PubMed ID: 32490726
[TBL] [Abstract][Full Text] [Related]
2. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Miesbach W; Makris M
Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
Schulman S
Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
[No Abstract] [Full Text] [Related]
4. Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer.
Rodriguez-Sevilla JJ; Rodó-Pin A; Espallargas I; Villar-García J; Molina L; Pérez Terán P; Vázquez Sanchez A; Masclans JR; Jiménez C; Millan Segovia R; Zuccarino F; Salar A; Rodriguez-Chiaradía DA
Arch Bronconeumol (Engl Ed); 2020 Nov; 56(11):758-759. PubMed ID: 32773301
[No Abstract] [Full Text] [Related]
5. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia.
Costanzo L; Palumbo FP; Ardita G; Antignani PL; Arosio E; Failla G;
J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):711-716. PubMed ID: 32561465
[TBL] [Abstract][Full Text] [Related]
6. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.
Pooni RS
Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158
[No Abstract] [Full Text] [Related]
7. Thromboembolic events and Covid-19.
Ribes A; Vardon-Bounes F; Mémier V; Poette M; Au-Duong J; Garcia C; Minville V; Sié P; Bura-Rivière A; Voisin S; Payrastre B
Adv Biol Regul; 2020 Aug; 77():100735. PubMed ID: 32773098
[TBL] [Abstract][Full Text] [Related]
8. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.
Godoy LC; Goligher EC; Lawler PR; Slutsky AS; Zarychanski R
CMAJ; 2020 Oct; 192(40):E1156-E1161. PubMed ID: 32816822
[No Abstract] [Full Text] [Related]
9. [COVID-19: Pathogenesis of a multi-faceted disease].
Bonny V; Maillard A; Mousseaux C; Plaçais L; Richier Q
Rev Med Interne; 2020 Jun; 41(6):375-389. PubMed ID: 32507520
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod.
Mallucci G; Zito A; Fabbro BD; Bergamaschi R
Mult Scler Relat Disord; 2020 Oct; 45():102414. PubMed ID: 32711296
[No Abstract] [Full Text] [Related]
11. Silencing of immune activation with methotrexate in patients with COVID-19.
Safavi F; Nath A
J Neurol Sci; 2020 Aug; 415():116942. PubMed ID: 32471659
[No Abstract] [Full Text] [Related]
12. Pulmonary vein thrombosis in COVID-19.
van Kruijsdijk RC; de Jong PA; Abrahams AC
BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33130591
[No Abstract] [Full Text] [Related]
13. Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era.
Rossi R; Coppi F; Talarico M; Boriani G
Eur J Intern Med; 2020 Jul; 77():158-160. PubMed ID: 32564905
[TBL] [Abstract][Full Text] [Related]
14. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection.
Llau JV; Ferrandis R; Sierra P; Hidalgo F; Cassinello C; Gómez-Luque A; Quintana M; Amezaga R; Gero M; Serrano A; Marcos P
Rev Esp Anestesiol Reanim (Engl Ed); 2020; 67(7):391-399. PubMed ID: 32591185
[TBL] [Abstract][Full Text] [Related]
15. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge.
Violi F; Pastori D; Cangemi R; Pignatelli P; Loffredo L
Thromb Haemost; 2020 Jun; 120(6):949-956. PubMed ID: 32349133
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and implications for thiopurine use.
Goodsall TM; Costello SP; Bryant RV
Med J Aust; 2020 Jun; 212(10):490-490.e1. PubMed ID: 32400020
[No Abstract] [Full Text] [Related]
17. How can we better predict pulmonary blood clots in patients hospitalised for COVID-19?
Bertoletti L; Huisman MV
Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32907888
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and Hypercoagulable State: A New Therapeutic Perspective.
Nascimento JHP; Gomes BFO; Carmo Júnior PRD; Petriz JLF; Rizk SI; Costa IBSDS; Lacerda MVG; Bacal F; Hajjar LA; Oliveira GMM
Arq Bras Cardiol; 2020 Jun; 114(5):829-833. PubMed ID: 32491074
[No Abstract] [Full Text] [Related]
19. The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy.
Lin HY
Chin J Traumatol; 2020 Aug; 23(4):190-195. PubMed ID: 32690231
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.
Moriarty PM; Gorby LK; Stroes ES; Kastelein JP; Davidson M; Tsimikas S
Curr Atheroscler Rep; 2020 Jul; 22(9):48. PubMed ID: 32710255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
